FEATURED NEWS

MATEC
October 20, 2017
Perinatal Antiretroviral Treatment Guidelines Updated October 19, 2017: The Recommendations for the use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States were recently updated. The following is a summary of what's changed in this revision: Recommendations for Use of MORE
MATEC
October 20, 2017
HHS Adult and Adolescent Antiretroviral Treatment Guidelines Updated The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) has released an updated version of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV Key guideline updates include the following: In the What to Start MORE
FDA
October 13, 2017
FDA Approved changes to the Sustiva label, Genvoya, Norvir, Descovy and more. On October 12, 2017 the FDA approved changed to the Sustiva (efavienz) package insert to: Update information on hepatotoxicity in DOSAGE and ADMINISTRATION, WARNINGS AND PRECAUTIONS, ADVERSEREACTIONS and Patient Information sections. Update CONTRAINDICATIONS and MORE
MATEC
August 17, 2017
Adult and Adolescent Opportunistic Infections Guidlines Updated The following sections of the Guidelines for the Prevemtion and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Hepatitis B Virus infection: This section was updated to include TAF/FTC as a treatment option for patients with HBV/HIV MORE
MATEC
August 1, 2017
Adult and Adolescent Opportunistic Infections Guidelines Updated July 28, 2017: The following sections of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Click here to view recently updated guidlines Sections of the Pneumocystis guidlines have been MORE